Soo‐Yon Rhee

12.1k total citations · 2 hit papers
86 papers, 4.8k citations indexed

About

Soo‐Yon Rhee is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Soo‐Yon Rhee has authored 86 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Infectious Diseases, 77 papers in Virology and 13 papers in Molecular Biology. Recurrent topics in Soo‐Yon Rhee's work include HIV/AIDS drug development and treatment (78 papers), HIV Research and Treatment (77 papers) and HIV/AIDS Research and Interventions (51 papers). Soo‐Yon Rhee is often cited by papers focused on HIV/AIDS drug development and treatment (78 papers), HIV Research and Treatment (77 papers) and HIV/AIDS Research and Interventions (51 papers). Soo‐Yon Rhee collaborates with scholars based in United States, United Kingdom and Portugal. Soo‐Yon Rhee's co-authors include Robert W. Shafer, Tommy F. Liu, Diane Bennett, Jonathan Schapiro, Jonathan Taylor, W. Jeffrey Fessel, Deenan Pillay, Daniel R. Kuritzkes, Paul Sandstrom and Susan Holmes and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Soo‐Yon Rhee

85 papers receiving 4.7k citations

Hit Papers

Drug Resistance Mutations for Surveillance of Transmitted... 2003 2026 2010 2018 2009 2003 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Soo‐Yon Rhee United States 36 3.9k 3.7k 877 694 357 86 4.8k
Lisa M. Demeter United States 34 4.7k 1.2× 4.4k 1.2× 544 0.6× 1.3k 1.9× 289 0.8× 84 6.1k
Jonathan Schapiro United States 36 5.0k 1.3× 4.8k 1.3× 516 0.6× 795 1.1× 479 1.3× 83 5.9k
Anders Sönnerborg Sweden 51 4.5k 1.2× 5.3k 1.4× 1.1k 1.3× 2.5k 3.7× 1.1k 3.1× 324 9.2k
Thomas Klimkait Switzerland 43 3.7k 0.9× 3.6k 1.0× 1.7k 2.0× 1.4k 2.1× 184 0.5× 186 7.1k
Michael S Saag United States 13 2.5k 0.6× 2.6k 0.7× 345 0.4× 1.1k 1.6× 221 0.6× 24 3.8k
Ronald Swanstrom United States 27 1.9k 0.5× 2.3k 0.6× 737 0.8× 617 0.9× 171 0.5× 58 2.9k
Steve Self United States 23 827 0.2× 1.3k 0.4× 499 0.6× 464 0.7× 85 0.2× 52 2.6k
Devan V. Mehrotra United States 30 879 0.2× 1.4k 0.4× 861 1.0× 847 1.2× 74 0.2× 107 4.0k
Kristel Van Laethem Belgium 35 2.2k 0.6× 2.3k 0.6× 718 0.8× 589 0.8× 322 0.9× 152 3.3k
Zabrina L. Brumme Canada 37 2.9k 0.7× 3.9k 1.0× 884 1.0× 880 1.3× 239 0.7× 176 5.3k

Countries citing papers authored by Soo‐Yon Rhee

Since Specialization
Citations

This map shows the geographic impact of Soo‐Yon Rhee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soo‐Yon Rhee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soo‐Yon Rhee more than expected).

Fields of papers citing papers by Soo‐Yon Rhee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soo‐Yon Rhee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soo‐Yon Rhee. The network helps show where Soo‐Yon Rhee may publish in the future.

Co-authorship network of co-authors of Soo‐Yon Rhee

This figure shows the co-authorship network connecting the top 25 collaborators of Soo‐Yon Rhee. A scholar is included among the top collaborators of Soo‐Yon Rhee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soo‐Yon Rhee. Soo‐Yon Rhee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chu, Carolyn, Kaiming Tao, Ava Avalos, et al.. (2024). Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping Review. Viruses. 16(3). 399–399. 23 indexed citations
2.
3.
Tao, Kaiming, Soo‐Yon Rhee, Philip L. Tzou, et al.. (2023). HIV-1 Group M Capsid Amino Acid Variability: Implications for Sequence Quality Control of Genotypic Resistance Testing. Viruses. 15(4). 992–992. 5 indexed citations
4.
Rhee, Soo‐Yon, et al.. (2022). Adherence to contemporary antiretroviral treatment regimens and impact on immunological and virologic outcomes in a US healthcare system. PLoS ONE. 17(2). e0263742–e0263742. 21 indexed citations
5.
Rhee, Soo‐Yon, et al.. (2022). Public availability of HIV-1 drug resistance sequence and treatment data: a systematic review. The Lancet Microbe. 3(5). e392–e398. 13 indexed citations
6.
Rhee, Soo‐Yon, et al.. (2021). Integrase Strand Transfer Inhibitor Resistance in Integrase Strand Transfer Inhibitor-Naive Persons. AIDS Research and Human Retroviruses. 37(10). 736–743. 11 indexed citations
7.
Ndembi, Nicaise, Jibreel Jumare, Peter Alabi, et al.. (2020). Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria. AIDS Research and Therapy. 17(1). 64–64. 8 indexed citations
8.
Tzou, Philip L., Soo‐Yon Rhee, & Robert W. Shafer. (2019). Amino Acid Prevalence of HIV-1 pol Mutations by Direct Polymerase Chain Reaction and Single Genome Sequencing. AIDS Research and Human Retroviruses. 35(10). 924–929. 2 indexed citations
9.
Chimukangara, Benjamin, Ayesha B. M. Kharsany, Richard Lessells, et al.. (2018). Moderate-to-High Levels of Pretreatment HIV Drug Resistance in KwaZulu-Natal Province, South Africa. AIDS Research and Human Retroviruses. 35(2). 129–138. 23 indexed citations
10.
Rhee, Soo‐Yon, Kris Sankaran, Vici Varghese, et al.. (2016). HIV-1 Protease, Reverse Transcriptase, and Integrase Variation. Journal of Virology. 90(13). 6058–6070. 68 indexed citations
11.
Ávila‐Ríos, Santiago, Omar Sued, Soo‐Yon Rhee, et al.. (2016). Surveillance of HIV Transmitted Drug Resistance in Latin America and the Caribbean: A Systematic Review and Meta-Analysis. PLoS ONE. 11(6). e0158560–e0158560. 34 indexed citations
12.
Theys, Kristof, Ricardo Camacho, Perpétua Gómes, Anne–Mieke Vandamme, & Soo‐Yon Rhee. (2015). Predicted residual activity of rilpivirine in HIV-1 infected patients failing therapy including NNRTIs efavirenz or nevirapine. Clinical Microbiology and Infection. 21(6). 607.e1–607.e8. 14 indexed citations
13.
Rhee, Soo‐Yon, José Luís Blanco, Tommy F. Liu, et al.. (2012). Standardized representation, visualization and searchable repository of antiretroviral treatment-change episodes. AIDS Research and Therapy. 9(1). 13–13. 2 indexed citations
14.
Blanco, J. L., Vici Varghese, Soo‐Yon Rhee, José M. Gatell, & Robert W. Shafer. (2011). HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications. The Journal of Infectious Diseases. 203(9). 1204–1214. 175 indexed citations
15.
Varghese, Vici, et al.. (2010). HIV-1 Integrase Sequence Variability in Antiretroviral Naïve Patients and in Triple-Class Experienced Patients Subsequently Treated with Raltegravir. AIDS Research and Human Retroviruses. 26(12). 1323–1326. 28 indexed citations
16.
Rhee, Soo‐Yon, W. Jeffrey Fessel, Tommy F. Liu, et al.. (2009). Predictive Value of HIV‐1 Genotypic Resistance Test Interpretation Algorithms. The Journal of Infectious Diseases. 200(3). 453–463. 37 indexed citations
17.
Kapoor, Amit, Beth Shapiro, Robert W. Shafer, et al.. (2008). Multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients. Retrovirology. 5(1). 7–7. 6 indexed citations
18.
Bembom, Oliver, Maya L. Petersen, Soo‐Yon Rhee, et al.. (2008). Biomarker discovery using targeted maximum‐likelihood estimation: Application to the treatment of antiretroviral‐resistant HIV infection. Statistics in Medicine. 28(1). 152–172. 36 indexed citations
19.
Rhee, Soo‐Yon, Rami Kantor, David Katzenstein, et al.. (2006). HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes. AIDS. 20(5). 643–651. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026